Gavin Spencer
Tracked across 2 events · 13 articles · First seen Jun 08, 2026 · Last active Aug 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
NicOx announced that its exclusive licensee in China, Paragon Therapeutics, has submitted a New Drug Application (NDA) to the Chinese China — National Medical Products Administration (NMPA) for NCX 470, a novel nitric oxide-donating bimatoprost…
Impact: Gavin Spencer is CEO of NicOx and commented on the submission, highlighting its significance for the company's pipeline.
Aug 10, 2026 · 6 articles
Business
Impact: Gavin Spencer is the Chief Executive Officer of NicOx and is listed as a contact for the company, but his direct involvement in the warrant expiration is administrative.
Jun 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Gavin Spencer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard